Surrozen, Inc.· SRZN

🇺🇸 US · MicroBroad USNASDAQ

HealthcareBiotechnologyWebsite

Price: $22.00
Day: +1.01%
Mkt Cap: $164.50M
52W Range: $9.03 – $35.00
Volume: 272.8K
Beta: 0.56

D25D FrameworkTTM Data

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Blog

stockoscope.com

Surrozen, Inc.

SRZN|Healthcare|Biotechnology

Comparing against 162 sector peers in United States · Micro Cap · Healthcare

Peer Comparison

Dimension 2 of 5

Revenue Growth

19%ile

-35.6%

Operating Margin

N/A

ROIC

42%ile

-38.0%

FCF Yield

46%ile

-20.5%

Growth & Cash Flow Quality

Percentile ranking across profitability growth and cash generation

EBITDA Growth

325.9%

EBIT Growth

319.3%

Net Income Growth

319.3%

OCF Growth

84.2%

FCF Growth

85.0%

Income Quality

0.10

Returns on Capital (TTM)

ROE(N/A)

N/A

PoorWeakAdequateStrongExceptional

ROCE(-38.7%)

41%ile

Average

PoorWeakAdequateStrongExceptional

ROA(N/A)

N/A

PoorWeakAdequateStrongExceptional

ROIC(-38.0%)

42%ile

Average

PoorWeakAdequateStrongExceptional

Profit Margins (TTM)

Gross Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

EBITDA Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Operating Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Net Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Leverage & Coverage (TTM)

Debt/Equity

9%ile

-0.02

Debt/Capital

5%ile

-0.03

Net Debt/EBITDA

85%ile

0.29

Interest Coverage

N/A

Liquidity (TTM)

Current Ratio

84%ile

11.9

Quick Ratio

85%ile

11.9

Cash Ratio

96%ile

11.2

WC Turnover

40%ile

0.08

Operational Efficiency (TTM)

Asset Turnover

18%ile

0.06

DSO

1%ile

244

Days Inventory

73%ile

0.00

Cash Conv. Cycle

N/A

TTM: Trailing Twelve Months · EBITDA: Earnings Before Interest, Taxes, Depreciation & Amortization · EBIT: Earnings Before Interest & Taxes · ROA: Return on Assets · ROIC: Return on Invested Capital · ROCE: Return on Capital Employed · ROE: Return on Equity · OCF: Operating Cash Flow · FCF: Free Cash Flow · DSO: Days Sales Outstanding · WC: Working Capital

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore SRZN on stockoscope.com→

Generated August 5, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

162 sector peers (United States · Micro Cap · Healthcare)

Relative Quality

SRZN Relative Quality Score

Ranked against 162 sector peers in United States · Micro Cap · Healthcare

Relative Quality

3.2/5

Adequate

vs 162 sector peers

Peer Rankings (7 of 10 available)

Relative Quality Score of 3.19/5 (Adequate) based on percentile rankings against 162 sector peers in United States · Micro Cap · Healthcare. Each pillar shows a 1-5 score plus the cohort percentile (e.g. 95p = top 5%); higher percentiles indicate stronger relative performance.Last updated August 5, 2026.

Top-Line and Profit Growth

How does the company's growth rate compare to peers?

Revenue Growth

19th percentile, Poor

Value: -35.61%
Percentile: 19%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

SRZN has a ttm revenue growth of -35.61% and ranks at the 19th percentile vs United States · Healthcare sector peers. Poor financial performance.

Margin Efficiency

Does the company maintain better profit margins than peers?

No data for Gross Margin is available for SRZN, so peer comparison is hidden for this metric. Try another metric.

Operational Efficiency

Is the company more operationally efficient than competitors?

Asset Turnover

18th percentile, Poor

Value: 0.06
Percentile: 18%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

SRZN has a ttm asset turnover of 0.06 and ranks at the 18th percentile vs United States · Healthcare sector peers. Poor financial performance.

Returns Overview

Does the company generate better returns on capital than peers?

No data for ROA is available for SRZN, so peer comparison is hidden for this metric. Try another metric.

Cash Flow Quality

How does the company's cash generation compare to peers?

Operating Cash Flow Growth

87th percentile, Exceptional

Value: 84.24%
Percentile: 87%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

SRZN has a ttm operating cash flow growth of 84.24% and ranks at the 87th percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Liquidity and Working Capital

Does the company maintain better liquidity positions than competitors?

Cash Ratio

96th percentile, Exceptional

Value: 11.18
Percentile: 96%
Score: 5/5

PoorWeakAdequateStrongExceptional

Analysis

SRZN has a ttm cash ratio of 11.18 and ranks at the 96th percentile vs United States · Healthcare sector peers. Top-tier financial performance.

Leverage and Coverage

Is the company's debt burden more manageable than peers?

Debt to Capital

5th percentile, Poor

Value: -0.03
Percentile: 5%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

SRZN has a ttm debt-to-capital of -0.03 and ranks at the 5th percentile vs United States · Healthcare sector peers. Poor financial performance.

Valuation Multiples

Is the company's stock valuation attractive relative to peers?

P / E Ratio

Insufficient peer data

Value: -0.53
Percentile: n/a
Score: n/a

PoorWeakAdequateStrongExceptional

Analysis

Not enough peer data to rank SRZN for ttm p/e ratio in this cohort.

Dividend and Shareholder Yield

Does the company deliver superior income to shareholders compared to peers?

No data for Dividend Yield is available for SRZN, so peer comparison is hidden for this metric. Try another metric.

Peer companies

The 162 companies SRZN is compared against across its sector and industry cohorts.

Surrozen, Inc.· SRZN

Peer Comparison

SRZN Relative Quality Score

Top-Line and Profit Growth

Revenue Growth

Revenue per Share Growth

Margin Efficiency

Operational Efficiency

Asset Turnover

Returns Overview

Cash Flow Quality

Operating Cash Flow Growth

Liquidity and Working Capital

Cash Ratio

Leverage and Coverage

Debt to Capital

Valuation Multiples

P / E Ratio

Dividend and Shareholder Yield

Peer companies

Peer Comparison

SRZN Relative Quality Score

Top-Line and Profit Growth

Revenue Growth

Revenue per Share Growth

Margin Efficiency

Operational Efficiency

Asset Turnover

Returns Overview

Cash Flow Quality

Operating Cash Flow Growth

Liquidity and Working Capital

Cash Ratio

Leverage and Coverage

Debt to Capital

Valuation Multiples

P / E Ratio

Dividend and Shareholder Yield

Peer companies

Surrozen, Inc.· SRZN

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies

Search stocks

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies